Back
68
50
Day Range
$10.95
$11.84
52-Week Range
$9.11
$12.83
Volume
100
50D / 200D Avg
$11.38
/
$10.56
Prev Close
$11.84
Price History
Financial Trends
Peer Comparison
vs Industrials sector median (890 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.0 | 14.4 |
| P/B | 0.0 | 1.9 |
| ROE % | 81.1 | 11.3 |
| Net Margin % | 30.3 | 6.5 |
| Rev Growth 5Y % | -19.1 | 8.4 |
| D/E | 1.3 | 0.6 |
Key Takeaways
Revenue declined -19.10% annually over 5 years
ROE of 81.10% indicates high profitability
Net margin of 30.31% shows strong profitability
Generating 19.83B in free cash flow
P/E of 0.04 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 26.89%
Growth
Revenue Growth (5Y)
-19.10%
Revenue (1Y)7.79%
Earnings (1Y)N/A
FCF Growth (3Y)293.56%
Quality
Return on Equity
81.10%
ROIC14.62%
Net Margin30.31%
Op. Margin21.30%
Safety
Debt / Equity
1.29
Current Ratio1.32
Interest Coverage61.36
Valuation
P/E Ratio
0.04
P/B Ratio0.03
EV/EBITDA0.84
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.79% | Revenue Growth (3Y) | 7.48% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 44.01% |
| Revenue Growth (5Y) | -19.10% | Earnings Growth (5Y) | 50.84% |
| Profitability | |||
| Revenue (TTM) | 142.91B | Net Income (TTM) | 43.32B |
| ROE | 81.10% | ROA | 14.29% |
| Gross Margin | 46.40% | Operating Margin | 21.30% |
| Net Margin | 30.31% | Free Cash Flow (TTM) | 19.83B |
| ROIC | 14.62% | FCF Growth (3Y) | 293.56% |
| Safety | |||
| Debt / Equity | 1.29 | Current Ratio | 1.32 |
| Interest Coverage | 61.36 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 0.04 | P/B Ratio | 0.03 |
| P/S Ratio | 0.01 | PEG Ratio | -0.03 |
| EV/EBITDA | 0.84 | Dividend Yield | 0.02% |
| Market Cap | 1.79B | Enterprise Value | 25.70B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 142.91B | 132.58B | 123.70B | 156.57B | 333.60B |
| Net Income | 43.32B | -27.81B | 20.89B | 15.64B | 8.37B |
| EPS (Diluted) | 272.03 | -181.92 | 130.96 | 98.42 | 52.48 |
| Gross Profit | 66.31B | 60.54B | 55.35B | 66.27B | 62.16B |
| Operating Income | 30.44B | 27.61B | 22.75B | 14.64B | 12.50B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 303.18B | 290.17B | 322.69B | 301.60B | 236.26B |
| Total Liabilities | 232.66B | 249.82B | 252.87B | 246.46B | 176.35B |
| Shareholders' Equity | 68.20B | 38.62B | 68.62B | 54.48B | 56.90B |
| Total Debt | 87.93B | 110.63B | 152.82B | 149.09B | 105.02B |
| Cash & Equivalents | 64.02B | 49.48B | 43.70B | 44.44B | 50.20B |
| Current Assets | 167.05B | 147.70B | 147.30B | 161.44B | 145.74B |
| Current Liabilities | 126.78B | 147.21B | 140.70B | 118.74B | 82.12B |
Strategy Scores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Light Compounder
#14 of 213
#152 of 658
Recent Activity
Entered
Capital Light Compounder
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026